PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
Barbara S. Gross, Michał Pawlak, Philippe Lefèbvre et al. · Nature Reviews Endocrinology · 2016
Cited by 774 works. doi:10.1038/nrendo.2016.135
Authors
References
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
- Brown Adipose Tissue: Function and Physiological Significance
- The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- Cold-Activated Brown Adipose Tissue in Healthy Men
- Mechanisms linking obesity with cardiovascular disease
- PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene.
- Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
- Ursodeoxycholic Acid or Clofibrate in the Treatment of Non–Alcohol–Induced Steatohepatitis: A Pilot Study